Showing results (241-250 of 351) with videos related to

Sort By:
Pageof 36
Oncotarget|October 13, 2016
Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blastsSeung-Ah Yahng, Myungshin Kim, Tae-Min Kim, et al.
Scientific Reports|March 20, 2021
The factors influencing clinical outcomes after leukapheresis in acute leukaemiaHowon Lee, Silvia Park, Jae-Ho Yoon, et al.
International Journal of Stem Cells|January 1, 2019
Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute LeukemiaTae Woo Kim, Sung-Soo Park, Ji-Young Lim, et al.
Acta Haematologica|January 11, 2022
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin ResponseDaehun Kwag, Jae-Ho Yoon, Gi June Min, et al.
Annals of Hematology|May 16, 2019
Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphomaYoung-Woo Jeon, Seugyun Yoon, Gi June Min, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2012
Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomesByung-Sik Cho, Sung-Eun Lee, Hae-Hiang Song, et al.
Journal of Hematology & Oncology|January 25, 2017
High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort studyJae-Ho Yoon, Hee-Je Kim, Dae-Hun Kwak, et al.
International Journal of Hematology|February 19, 2005
Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in KoreaSu-Mi Choi, Dong-Gun Lee, Jung-Hyun Choi, et al.
Cancers|March 29, 2023
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid LeukemiaSu-Yeon Bang, Silvia Park, Daehun Kwag, et al.
European Journal of Haematology|October 11, 2022
Cytogenetic and molecular characteristics and outcomes of adult patients with early T-cell precursor acute lymphoblastic leukemiaJae-Ho Yoon, Hoon Seok Kim, Gi June Min, et al.
Pageof 36